| 标题 |
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:J. Bourhis; A. Auperin; Christian Borel; G. Lefebvre; S. Racadot; et al 出版日期:2025-12-22 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)